WELLS FARGO & COMPANY/MN - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 188 filers reported holding AKERO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,306,751
+2.0%
45,606
-5.9%
0.00%0.0%
Q2 2023$2,262,177
+61.5%
48,451
+32.3%
0.00%
Q1 2023$1,400,966
+1307.0%
36,617
+1915.2%
0.00%
Q4 2022$99,571
-93.4%
1,817
-95.9%
0.00%
Q3 2022$1,506,000
+8758.8%
44,235
+2354.8%
0.00%
Q2 2022$17,000
-70.7%
1,802
-55.9%
0.00%
Q1 2022$58,000
-78.8%
4,088
-68.4%
0.00%
Q4 2021$274,000
+2390.9%
12,950
+2614.9%
0.00%
Q3 2021$11,000
+83.3%
477
+110.1%
0.00%
Q2 2021$6,000
-45.5%
227
-39.8%
0.00%
Q1 2021$11,000
-98.6%
377
-98.7%
0.00%
Q4 2020$774,000
+294.9%
30,022
+369.6%
0.00%
Q3 2020$196,000
-63.2%
6,393
-70.0%
0.00%
Q2 2020$532,000
+309.2%
21,334
+247.2%
0.00%
Q1 2020$130,000
+85.7%
6,145
+94.2%
0.00%
Q4 2019$70,000
+677.8%
3,164
+719.7%
0.00%
Q3 2019$9,0003860.00%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ATP Life Science Ventures, L.P. 5,830,203$179,512,00024.20%
venBio Partners LLC 2,444,311$75,260,00011.44%
Versant Venture Management, LLC 777,727$23,946,0004.38%
Redmile Group, LLC 2,336,357$71,936,0001.32%
Vivo Capital, LLC 571,833$17,607,0001.02%
Cormorant Asset Management, LP 859,550$26,466,0001.02%
Boxer Capital, LLC 831,495$25,602,0000.88%
Integral Health Asset Management, LLC 85,000$2,617,0000.80%
EAM Global Investors LLC 49,718$1,531,0000.56%
Crawford Lake Capital Management, LLC 43,826$1,349,0000.56%
View complete list of AKERO THERAPEUTICS INC shareholders